SLC27A2 and neoplasm: This data implies that any potential therapeutic effects of lipofermata may not only be related to its ability to inhibit FATP2, but may also be affected by the levels of other lipids whose levels can be modulated by FATP2, among them (dihydro)ceramide, a critical lipid involved in regulating normal cell and tumor cell growth (36).